Renaissance Technologies’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Buy |
1,047,600
+866,800
| +479% | +$9.73M | 0.02% | 972 |
|
|
2025
Q1 | $826K | Sell |
180,800
-182,600
| -50% | -$834K | ﹤0.01% | 2522 |
|
|
2024
Q4 | $2.05M | Sell |
363,400
-211,386
| -37% | -$1.19M | ﹤0.01% | 2040 |
|
|
2024
Q3 | $2.78M | Buy |
574,786
+100,286
| +21% | +$485K | ﹤0.01% | 1806 |
|
|
2024
Q2 | $2.32M | Buy |
474,500
+275,173
| +138% | +$1.34M | ﹤0.01% | 1790 |
|
|
2024
Q1 | $2.65M | Buy |
199,327
+34,760
| +21% | +$462K | ﹤0.01% | 1835 |
|
|
2023
Q4 | $2.29M | Buy |
+164,567
| New | +$2.29M | ﹤0.01% | 1870 |
|
|
2022
Q3 | – | Sell |
-311,200
| Closed | -$4.76M | – | 4433 |
|
|
2022
Q2 | $4.76M | Buy |
+311,200
| New | +$4.76M | 0.01% | 1601 |
|
|
2022
Q1 | – | Sell |
-24,000
| Closed | -$885K | – | 4489 |
|
|
2021
Q4 | $885K | Buy |
+24,000
| New | +$885K | ﹤0.01% | 2740 |
|